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IntroductIon
The mononuclear phagocyte system comprises three types 
of cells: monocytes, macrophages, and DCs, as well as their 
committed bone marrow progenitors (van Furth et al., 1972; 
Yona and Gordon, 2015). Collectively, the cells of the mono-
nuclear phagocyte system play key functions in maintaining 
tissue homeostasis during steady state as well as orchestrating 
the genesis and resolution of the immune response (Davies et 
al., 2013; Wynn et al., 2013; Ginhoux and Jung, 2014).
It is now recognized that the majority of tissue macro-
phage populations are seeded before birth (Ginhoux et al., 
2010; Schulz et al., 2012; Guilliams et al., 2013; Hashimoto et 
al., 2013; Yona et al., 2013; Mass et al., 2016) and maintained 
via self-proliferation throughout adulthood with minimal 
monocyte input (Soucie et al., 2016). Conversely, DCs and 
monocytes arise from distinct adult hematopoietic stem cell 
precursors in the bone marrow (Fogg et al., 2006; Naik et al., 
2007; Onai et al., 2007, 2013; Liu et al., 2009; Hettinger et al., 
2013; Breton et al., 2015; Lee et al., 2015).
Circulating monocytes represent a versatile and dynamic 
cell population, composed of multiple subsets which differ 
in phenotype, size, morphology, and transcriptional profiles 
and are defined by their location in the blood (Geissmann 
et al., 2003; Cros et al., 2010; Ingersoll et al., 2010; Wong 
et al., 2011; Mildner et al., 2013a). These discrete mono-
cyte subsets can be distinguished by the expression of CD14 
and CD16 in humans and Ly6C, CCR2, and CX3CR1 in 
mice (Ziegler-Heitbrock et al., 2010). In humans, CD14+ 
CD16− (classical) monocytes make up ∼85% of the circu-
lating monocyte pool, whereas the remaining ∼15% consist 
of CD14+ CD16+ (intermediate) and CD14lo CD16+ (non-
classical) monocytes (Passlick et al., 1989; Wong et al., 2011). 
Similarly, in mice, two populations of monocytes have been 
described: Ly6Chi CCR2+ CX3CR1int and Ly6Clo CCR2− 
CX3CR1hi, representing classical and nonclassical monocytes, 
respectively (Geissmann et al., 2003). Monocyte egression 
from the bone marrow requires expression of the chemok-
ine receptor CCR2, which is restricted to classical mono-
cytes (Shi and Pamer, 2011).
Classical monocytes are rapidly recruited to sites of in-
fection (Serbina and Pamer, 2006; Liao et al., 2017) and in-
jury (Nahrendorf et al., 2007; Zigmond et al., 2014), where 
they exhibit considerable functional plasticity (Arnold et al., 
2007; Avraham-Davidi et al., 2013). Interestingly, classical 
monocytes replenish resident peripheral monocyte–derived 
cells under steady-state conditions (Varol et al., 2009; Tamout-
ounour et al., 2013; Bain et al., 2014; Guilliams et al., 2014). 
In humans, the monocyte pool comprises three subsets (classical, intermediate, and nonclassical) that circulate in dynamic 
equilibrium. the kinetics underlying their generation, differentiation, and disappearance are critical to understanding both 
steady-state homeostasis and inflammatory responses. Here, using human in vivo deuterium labeling, we demonstrate that 
classical monocytes emerge first from marrow, after a postmitotic interval of 1.6 d, and circulate for a day. Subsequent label-
ing of intermediate and nonclassical monocytes is consistent with a model of sequential transition. Intermediate and nonclas-
sical monocytes have longer circulating lifespans (∼4 and ∼7 d, respectively). In a human experimental endotoxemia model, a 
transient but profound monocytopenia was observed; restoration of circulating monocytes was achieved by the early release 
of classical monocytes from bone marrow. the sequence of repopulation recapitulated the order of maturation in healthy 
homeostasis. this developmental relationship between monocyte subsets was verified by fate mapping grafted human classical 
monocytes into humanized mice, which were able to differentiate sequentially into intermediate and nonclassical cells.
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Nonclassical monocytes have been proposed to act as custo-
dians of vasculature by patrolling endothelial cell integrity in 
an LFA-1–dependent fashion (Auffray et al., 2007).
During steady state, rodent blood monocyte subsets rep-
resent stages of a developmental sequence; classical monocytes 
have been shown to convert into nonclassical monocytes over 
time (Sunderkötter et al., 2004; Yrlid et al., 2006; Varol et al., 
2007; Yona et al., 2013; Thomas et al., 2016). However, it re-
mains to be shown what, if any, relationships exist among the 
three principal human monocyte subsets and how long each 
of these subsets resides in the circulation.
Although the vast majority of information concerning 
mononuclear phagocyte ontogeny, function, and kinetics is 
derived from mouse studies, due to the challenging nature 
of performing studies in a clinical setting, some important 
insights into human monocyte biology have been gained 
from studying pathological states. Patients with a GATA2 
mutation (encoding the GATA-binding protein 2) have an 
absence of all blood monocytes; despite this, their resident 
dermal and lung macrophages remain unaffected, suggesting 
that the development of these populations is independent of 
blood monocytes (Bigley et al., 2011). Interestingly, patients 
with rheumatoid arthritis exhibit an increase in circulating 
intermediate monocytes (Cooper et al., 2012). Furthermore, 
stroke patients have been reported to increase their interme-
diate monocytes 2 d after their initial insult, and this increase 
inversely correlated with mortality (Urra et al., 2009). These 
data raise the questions of whether and how circulating human 
monocyte subsets are related, how long each population cir-
culates, and what impact inflammation has on this process.
Fifty years ago, van Furth and Cohn performed a series 
of elegant studies examining monocyte dynamics in rodents 
with 3H-thymidine. They concluded that monocytes tran-
sit from the bone marrow to the blood, with a circulating 
half-life of ∼22 h (van Furth and Cohn, 1968). More recently, 
studies in mice demonstrated that classical monocytes have a 
half-life of <1 d before converting into nonclassical mono-
cytes with a half-life of ∼2.2 d (Yona et al., 2013). Neverthe-
less, the fate and kinetics of human monocyte subsets under 
steady state and inflammation remain to be resolved. A major 
breakthrough in examining in vivo human leukocyte kinet-
ics came with the advent of nontoxic stable isotope labeling 
approaches (Macallan et al., 1998; Busch et al., 2007). Spe-
cifically, the deuterium from deuterium-labeled glucose or 
heavy water incorporates stably into the backbone of DNA 
of dividing cells. The deuterium-glucose labeling approach is 
particularly suited to the study of rapidly dividing cells and 
has been applied in humans to study the turnover of T cell 
populations such as regulatory T cells (Vukmanovic-Stejic et 
al., 2006), to memory T cell subsets in HIV infection (Zhang 
et al., 2013), and, more recently, to cells of the innate immune 
system, such as neutrophils (Lahoz-Beneytez et al., 2016).
Here, we report a series of studies investigating the de-
velopment and kinetics of human monocyte subpopulations. 
We hypothesized that the fate and kinetics of the three mono-
cyte subsets (classical, intermediate, and nonclassical) were in-
timately linked and could be defined in kinetic terms. We 
first investigated the steady-state kinetics in healthy human 
volunteers using in vivo deuterium-labeled glucose as a pre-
cursor. We then repeated these studies in the context of endo-
toxin-induced systemic inflammation, where we observed a 
transient depletion of almost the entire circulating monocyte 
pool; in this way, we were able to study the early repopu-
lation of an “empty” blood compartment. Finally, we tested 
our sequential development hypothesis in the humanized 
MIS TRG mouse (Rongvaux et al., 2014) to build a compre-
hensive picture of how human monocyte subsets are regu-
lated in steady state and systemic inflammation.
reSultS and dIScuSSIon
characterization of human monocyte subset 
kinetics under steady state
The literature has not always clearly distinguished between 
monocyte subsets, making interpretation confusing. We chose 
to follow a systematic strategy to identify the three conven-
tional monocyte subsets of interest. Lin− (CD3, CD19, CD20, 
CD56, and CD66b) HLA-DR+ cells were separated into (1) 
CD14+CD16− classical monocytes, (2) CD14+CD16+ in-
termediate monocytes, and (3) CD14loCD16+ nonclassical 
monocytes (Fig. 1 a; Ziegler-Heitbrock et al., 2010). In addi-
tion to CD14 and CD16 expression, we confirmed additional 
membrane marker expression between monocyte subsets 
(Fig. 1 b and Fig. S1 a; Ingersoll et al., 2010). Interestingly, these 
data demonstrate the discrete nature of monocyte subsets is 
a continuum of more than just CD14 and CD16 expression.
To investigate monocyte kinetics under normal phys-
iological homeostatic conditions, we administered a short 
pulse (3 h) of deuterium-labeled glucose (6,6-2H2-glucose) to 
healthy human volunteers and analyzed flow-sorted mono-
cyte subsets at sequential time points thereafter for deute-
rium incorporation (Fig. 1 c; Macallan et al., 2009; Westera 
et al., 2013). Analysis of deuterium labeling data revealed that 
monocyte subsets exhibited a highly consistent pattern in all 
volunteers studied. Significantly, there was no deuterium la-
beling for the first 24 h after administration, consistent with a 
postmitotic “maturation” phase preceding release from bone 
marrow into the circulation. We then observed early integra-
tion of deuterium in classical monocytes, reaching a peak 3 d 
after labeling (Fig. 1 d). At these early time points, interme-
diate monocytes were also labeled with deuterium but at a 
much lower level than classical monocytes. No label was ob-
served in nonclassical monocytes until day 7. This pattern of 
sequential appearance of labeling in human monocyte subsets 
is reminiscent of previous studies in experimental models in 
rodents, where classical monocytes convert into nonclassical 
monocytes over time (Sunderkötter et al., 2004; Varol et al., 
2007; Yona et al., 2013; Gamrekelashvili et al., 2016).
This chronological acquisition of deuterium by cir-
culating monocyte subsets is most likely to be explained 
by a sequential ontogeny scenario in which deuterium is 
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incorporated into precursors that differentiate into classical 
monocytes in bone marrow; these classical monocytes are re-
leased into the circulation, where they undergo one of two 
fates: they either differentiate into intermediate monocytes 
or disappear by death or migration. Similarly, intermediate 
monocytes either leave the blood (by death or migration) or 
differentiate into nonclassical monocytes. The likelihood of 
each onward differentiation step (classical to intermediate and 
then intermediate to nonclassical) was denoted by the rate 
αr for each subpopulation, resulting in a corresponding rate 
of loss from the circulating pool (by death or migration) of 
(1-α)r. This model is summarized in Fig. 1 e. The alternative 
parallel ontogeny scenario was also considered; in this model, 
the three subsets arise from separate linages, each with its own 
distinct postmitotic kinetics. This model could certainly be 
made to fit the data mathematically, as it has so many free 
parameters, but was deemed unlikely on biological grounds. 
First, it predicts the presence of intermediate and nonclassical 
monocytes in the bone marrow, contrary to our observations 
where only classical monocytes were detected following bone 
marrow biopsy (Fig.  1  f; blood monocyte contamination 
could be detected in bone marrow aspirate), and second, be-
cause it would be inconsistent with information from studies 
in rodents (Sunderkötter et al., 2004; Yrlid et al., 2006; Varol 
et al., 2007; Yona et al., 2013; Gamrekelashvili et al., 2016). 
In the sequential model used here (Fig. 1 e) proliferation is 
restricted to the bone marrow; we excluded models in which 
circulating subsets proliferate in the blood on the basis of (1) 
the absence of any deuterium enrichment in such cells 24 h 
after labeling (Fig.  1  d) and (2) the absence of markers of 
cell cycling (Fig. S1 b).
Results from fitting the model to the experimental 
data are shown in Table 1 and Fig. S2. We found that classical 
monocytes have a very short circulating lifespan (mean 1.0 ± 
0.26 d). Most cells leave the circulation or die, whereas the re-
maining cells transition to intermediate monocytes. Interme-
diate monocytes have a longer lifespan (mean 4.3 ± 0.36 d) 
and all transition to nonclassical monocytes. Nonclassical 
monocytes in turn have the longest lifespan in blood (mean 
7.4 ± 0.53 d), before either leaving the circulation or dying, 
as summarized graphically in Fig. 1 g.
Other studies have found evidence for a delay between 
intermediate monocytes and nonclassical monocytes (Tak, T., 
et al. 2016 British Society of Immunology/Dutch Society for 
Immunology Congress. Poster P207). We therefore investi-
gated the consequences of including such a delay (Δ3) in our 
model. The goodness of the fits (ssr) were very similar with 
or without a delay. However, in three of four subjects, the 
model without Δ3 outperformed the model with Δ3 in terms 
of the corrected Akaike information criterion (Table S1). The 
estimates of monocyte lifetime were very similar for models 
with or without Δ3 (Table S2).
Our data are consistent with earlier murine studies, 
which provided evidence that the lifespan of each monocyte 
subpopulation varies; classical Ly6Chi monocytes have shorter 
circulating half-lives (20 h) than nonclassical Ly6Clo mono-
cytes (2.2 d; Yona et al., 2013). The difference in circulating 
half-life between monocyte subsets is likely to correlate with 
their functional attributes. Classical monocytes replenish the 
large resident monocyte-derived population of the gut (Bain 
et al., 2014) and skin (Tamoutounour et al., 2013) and are 
poised to migrate to sites of inflammation, where they display 
Figure 1. In vivo labeling and a methodological approach of modeling human monocyte subset kinetics at steady state. (a) Polychromatic flow 
cytometry gating strategy for blood monocyte subsets. Peripheral blood mononuclear phagocyte cells were identified as Lin− (CD3, CD19, CD20, CD56, 
CD66b) HLA-DR+ cells. This population comprises classical monocytes (CD14+ CD16−: black gated population), intermediate monocytes (CD14+ CD16+: 
gray gated population), and nonclassical monocytes (CD14lo CD16+: red gated population) representative of >10 subjects. Representative cytospin images 
from 10 healthy volunteers stained with hematoxylin and eosin (bottom). Bar, 25 µm. (b) Flow cytometry viSNE analysis of monocyte subsets illustrating 
membrane expression for CCR2, CD62L, CD36, CD64, CD11b, CD11c, HLA-DR, SLAN, and CX3CR1, representative of eight healthy volunteers. (c) Schematic 
of protocol for labeling newly divided cells. Healthy volunteers received 20 g deuterium-labeled glucose over 3 h. Monocytes subsets were then sorted 
from whole blood over a 30-d period, DNA was extracted to quantify the deuterium enrichment in each monocyte subset by gas chromatography mass 
spectrometry. (d) Percentage of deuterium label in peripheral blood classical (black), intermediate (gray), and nonclassical (red) monocytes following oral 
admission of deuterated glucose in four healthy volunteers; values shown are mean ± SEM. (e) Model of circulating monocyte kinetics. Cartoon depicts 
the sequential model for the fate of circulating monocyte subsets. Monocytes mature in the bone marrow, where their precursors proliferate at a rate p. 
Classical monocytes leave the bone marrow at rate r1, after a delay of Δ1 days between the last proliferation and release into the circulation. In the blood, 
classical monocytes either mature into intermediate monocytes at rate α2 r2, where α = proportion of the subset, or they disappear from the blood (either 
by death or by moving to other organs) at rate (1–α2)r2. The total disappearance rate is thus r2. Likewise, a proportion α3 of the intermediate monocyte 
subset develop into nonclassical monocytes, the remainder disappearing from blood. A parameter Δ3 has been included to allow for a potential delay in the 
differentiation of intermediate monocyte to nonclassical monocytes. (f) Polychromatic flow cytometry comparing BM with circulating monocyte subsets. 
Human BM was initially gated as Lin−HLA-DR+. Human BM obtained as either an aspirate or femoral head excavated biopsy was examined by flow cytometry 
to identify resident monocyte subsets. Only classical monocytes could be detected in the biopsy specimen. These data are representative of three donors 
for each procedure. (g) Summary of the steady-state kinetics for monocyte subsets. Figures in black bold text denote lifespans in each compartment figures 
in italics denote the relative probability of each cell undergoing the respective fate (death/disappearance versus phenotype transition). Progenitor cells in 
the bone marrow proliferate at rate of 0.42/d (blue), where the postmitotic cells remain within the bone marrow for 1.6 d before being released into the 
circulation as classical monocytes. Classical monocytes contribute 87% to the total monocyte pool, whereas intermediate and nonclassical monocytes make 
up 5% and 8%, respectively. 99% of classical monocytes leave the circulation, and 1% go onto become intermediate monocytes. 100% of intermediate 
monocytes mature in the circulation to become nonclassical monocytes under steady state.
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a pro- or antiinflammatory phenotype depending on micro-
environmental cues (Mildner et al., 2013b). More recently, 
these cells have been shown to enter tissues under steady state 
and transport antigen to lymph nodes without differentiating 
(Jakubzick et al., 2013). Less is known regarding the fate of 
nonclassical monocytes, but it is well documented that mouse 
and human nonclassical monocytes patrol the endothelium 
(Auffray et al., 2007; Cros et al., 2010) and represent a more ter-
minally differentiated blood resident monocyte–derived cell.
Human endotoxemia provokes the early release 
of bone marrow monocytes
We next investigated the response of monocytes to major 
systemic inflammation using the human experimental endo-
toxemia model (Fig. 2 a; Fullerton et al., 2016). A single i.v. 
injection of endotoxin induced a profound acute monocyto-
penia, following which, population numbers in blood recov-
ered rapidly (Fig. 2, b and c). Corresponding in vitro studies 
have reported functional differences in the response to LPS 
between monocyte subpopulations (Cros et al., 2010).
Volunteers challenged with 2 ng/kg endotoxin (Fig.   
2  a) experienced a complete loss of circulating Lin− 
HLA-DR+ cells within the first 2 h after receiving endotoxin 
(Fig.  2  b). Strikingly, repopulation of the blood mono-
cyte pool began very rapidly. Classical monocytes were the 
first subset to repopulate the circulation and appeared as 
early as 4  h after endotoxin; intermediate and nonclassical 
monocytes remained absent from the circulation until 24 h 
(Fig.  2  b). By day 7, monocyte numbers had returned to 
steady-state values (Fig. 2 c).
These data are consistent with previous studies in ro-
dents, in which there is an expansion in circulating classical 
Ly6Chi monocytes following both peripheral and systemic 
inflammation (Shi et al., 2011; Griseri et al., 2012; Heidt et 
al., 2014). Interestingly, the recovery surge of monocyte sub-
sets following systemic inflammation recapitulates the order 
in which deuterium labeling appeared in monocyte subsets in 
healthy homeostasis (Fig. 1 d).
We set out to address whether classical monocytes mar-
ginate and then return to the circulation or whether their 
reappearance is due to an early “emergency” release from the 
bone marrow monocyte pool. To address this question, volun-
teers were pulsed with deuterium-labeled glucose 20 h before 
endotoxin challenge. We deliberately chose this time point 
preendotoxin, as we knew from the healthy labeling data that 
at this time point after labeling, no circulating monocytes 
would normally be labeled (Fig.  1  d), whereas cells in the 
postmitotic phase within the bone marrow pool could be 
expected to be highly labeled. Hence, unlabeled cells reap-
pearing from margination could be readily distinguished from 
highly labeled cells released early from bone marrow.
We observed very high levels of deuterium labeling 
in classical monocytes at 8 h following endotoxin challenge 
(Fig. 2 d), demonstrating that these cells must have been re-
cently released from the bone marrow. Although it cannot be 
confirmed that all classical monocytes were released from the 
bone marrow, due to the limitations of human experimenta-
tion, the fraction labeled were very similar to those seen 72 h 
after labeling in healthy homeostasis and are consistent with 
the proposal that most, if not all, circulating monocytes in the 
early recovery phase are bone marrow derived, rather than 
monocytes returning from a marginated pool. Certainly, it is 
clear that the transition time from bone marrow to the circu-
lation is reduced dramatically in comparison to steady state as 
a result of the emergency release of classical monocytes.
classical human monocytes have the potential to give rise 
to intermediate and nonclassical monocytes
Given the sequential maturation of monocyte subsets during 
healthy homeostasis and, reappearance of monocytes follow-
ing endotoxin challenge, we investigated the developmental 
relationship between human monocytes subsets in a human-
ized animal model. To this end, we analyzed the fate of clas-
sical human monocytes isolated from healthy volunteers and 
grafted into MIS TRG mice (Fig. 3). The MIS TRG mouse is 
a novel humanized mouse containing human versions of five 
genes encoding the cytokines thrombopoietin, IL-3, CSF2 
(GM-CSF), SIRPα, and CSF1 (M-CSF) that help maintain 
human mononuclear phagocyte development (Rongvaux et 
al., 2014; Deng et al., 2015). Recipient mice were sacrificed 
at various time points following transfer, and peripheral blood 
was subjected to flow cytometry analysis. 10 min after trans-
Table 1. derived variables for in vivo human monocyte kinetics
Subject Proliferation Delay Lifespans Pool sizes Percentage transiting
BM BM to blood marrow cM IM ncM cM IM ncM cM→IM IM→ncM
per d d d d d d % % % % %
Subject 1 0.48 1.53 1.04 1.37 4.29 6.44 80 8 12 3.2 100
Subject 2 0.28 1.70 1.77 0.5 5.26 7.52 83 7 10 0.8 100
Subject 3 0.26 1.61 1.9 0.62 3.55 8.28 90 3 7 0.6 100
Subject 4 0.64 1.70 0.78 1.54 4.11 N/R 96 2 2 0.8 N/R
Mean 0.42 1.64 1.37 1.01 4.30 7.41 87 5 8 1.4 100
SEM 0.09 0.04 0.27 0.26 0.36 0.53 3.59 1.47 2.17 0.62 0
Proliferation rate, lifespans, delays, and percentage of monocyte transitioning between subpopulations by subject for the model in which Δ3 = 0. Pool sizes were determined by flow cyto-
metric analysis and were an input variable in the model. CMs, classical monocytes; IMs, intermediate monocytes; NCMs, nonclassical monocytes; N/R, data fit not resolved due to low labeling 
rates in nonclassical monocytes in subject 4.
o
n
 June 19, 2017
D
ow
nloaded from
 
Published June 12, 2017
Human monocyte kinetics | Patel et al.6
Figure 2. Sequential reappearance of monocytes subsets after endotoxin challenge. (a) Schematic protocol for administrating deuterium-labeled 
glucose 20 h before i.v. endotoxin 2 ng/kg in healthy volunteers. Classical monocytes were then sorted from whole blood, DNA extracted, and deuterium 
enrichment quantified by gas chromatography mass spectrometry over the ensuing 8 d. (b) Flow cytometry analysis of human monocyte subsets at 0, 2, 4, 
8, 24, 48, and 72 h and 7 d after i.v. administration of endotoxin, representative of 10 individuals. (c) Time course of absolute monocyte numbers at selected 
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fer engraftment, (human) CD45+ cells detected in recipient 
blood displayed a classical monocyte phenotype; by 24 h, the 
grafted cells had transitioned to intermediate monocytes, 
and by 96  h, all grafted cells were nonclassical monocytes 
(Fig. 3 c). Collectively, this establishes for the first time that 
human classical monocytes have the potential to become in-
termediate monocytes before finally differentiating into non-
classical monocytes in vivo. These studies are reminiscent of 
previous rodent experiments, where classical Ly6Chi mono-
cytes were shown to convert into nonclassical cells over time 
(Varol et al., 2007; Yona et al., 2013; Gamrekelashvili et al., 
2016). Although the conversion times differed from those seen 
in the in vivo deuterium-labeling studies, this is most likely 
due to grafted cells already being mature classical monocytes. 
A recent murine study has demonstrated Notch2 signaling is 
required for classical Ly6C+ monocytes to convert to non-
classical monocytes (Gamrekelashvili et al., 2016). Due to the 
challenging nature of ex vivo monocyte culture, this has not 
been demonstrated in human cells, but hopefully, future ad-
vances in cell culture will enable us to fully comprehend the 
mechanisms involved in human monocyte conversion.
Collectively, these data suggest that monocyte pre-
cursors first differentiate into classical monocytes that are 
retained in marrow for a postmitotic maturation phase of 
∼38 h. As a result of this delay, a reserve population of newly 
generated classical monocytes is retained in bone marrow. 
Following acute systemic inflammation, this reserve popula-
tion is rapidly released to replace lost circulating cells. Once in 
the circulation, both in vivo modeling and humanized animal 
experiments are most consistent with a model in which most 
classical monocytes leave the circulation after a circulating 
lifespan of ∼1 d. A small proportion of classical monocytes 
further mature into intermediate monocytes in the circula-
tion; most of these cells finally convert to nonclassical mono-
cytes before leaving the circulation. Clearly, this is a very 
tightly controlled process, with remarkably consistent results 
between individuals. Establishing the regulatory mechanisms 
that control these processes will be the next step in exploring 
human monocyte biology regulation. Understanding the fun-
damental regulation of monocyte subset generation, differen-
tiation, and function will dictate future therapeutic avenues, 
depleting them when they are detrimental and boosting them 
when they are beneficial.
MaterIalS and MetHodS
Subjects and ethics
Subjects were healthy volunteers (20 males and 5 females). 
All volunteers gave written informed consent, and all studies 
were conducted according to the principles of the declaration 
of Helsinki after approval by the relevant institutional review 
boards (for deuterium and steady-state experiments, NRES 
Committee West London [10/H0803/102] and University 
College London Research Ethics Committee [p8081/001], 
and for the endotoxemia study [5060/001]). Human bone 
marrow samples were obtained from hematopoietic stem 
cell donors or femoral heads following total hip replacement. 
Newcastle and North Tyneside Research Ethics Committee 
approved the bone marrow biopsy (REC 14/NE/113) and 
hip (REC 14/NE/1212) procedures.
Flow cytometry and cell sorting
PBMCs were isolated by Ficoll-Paque Plus (GE Health-
care) by density centrifugation (1,000 g, low acceleration, no 
brake) and then resuspended in PBS containing 2% FCS and 
2 mM EDTA. Isolated PBMCs were incubated with Human 
Trustain FcX (BioLegend) before labeling with the follow-
ing antibodies obtained from BioLegend (unless otherwise 
stated): CD3 (HIT3a), CD11b (ICRF44), CD11c (B-ly6; 
BD), CD14 (M5E2), CD16 (3G8), CD19 (HIB19), CD20 
(2H7), CD33 (WM53), CD36 (5–271), hCD45 (H130), 
mCD45 (30F11), CD56 (MEM-188), CD62L (DREG-56), 
CD64 (10.1), CD66b (G10F5), HLA-DR (G46-6; BD), 
CX3CR1 (2A9-1), CCR2 (KO36C2), and SLAN (MDC-8; 
Miltenyi Biotec). DAPI staining was performed in specified 
experiments following surface staining, and cells were fixed 
and permeabilized in Fixation Buffer and Intracellular Stain-
ing Permeabilization Wash Buffer (BioLegend) according to 
the manufacturer’s instructions before incubation with 0.05 
ng/ml DAPI. For a positive control, the human monocyte 
cell line Mono Mac 6 was used (Ziegler-Heitbrock et al., 
1988). For bone marrow isolation, cells from hip arthroplasty 
specimens and bone fragments were excavated from femoral 
heads. The cavity and fragments were washed with PBS and 
filtered through a 50-µm filter. Mononuclear cells were pre-
pared from the resulting cell suspension or bone marrow aspi-
rate from hematopoietic stem cells healthy donors by density 
centrifugation as described for PBMCs. Cells were stained for 
CD3 (SK7-Leu9; BD), CD19 (HIB19; BD), CD20 (L27; BD), 
CD7 (4H9; BD), CD14 (M5E2; BioLegend), CD16 (3G8; 
BD), HLA-DR (G46-6; BD), and DAPI (Sysmex) for dead 
cell exclusion. Flow cytometry was performed with LSR 
Fortessa X20 (BD) and cell sorting by FACS Aria II (BD), 
and data were analyzed offline with FlowJo (Tree Star) and 
Cytobank (Cytobank, Inc.).
deuterium labeling
Deuterium labeling followed a shortened version of published 
protocols (Macallan et al., 2009; Westera et al., 2013). Subjects 
received 20 g deuterium-labeled glucose (6,6-2H2-glucose; 
Cambridge Isotopes) as an oral solution in half-hourly aliquots 
time points following endotoxin challenge for classical, intermediate, and nonclassical monocytes (mean ± SEM × 109/L of three individual subjects; note 
the different scale for each subset). (d) Comparison of deuterium-labeled classical monocyte egression from the BM under normal physiological conditions 
(triangles, dashed line, four subjects) and after endotoxin challenge (circles, solid line, three subjects). Values represent mean ± SEM.
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over 3 h, following a priming dose equivalent to 1.8 h dosing at 
time 0. Blood glucose enrichment was monitored at baseline, 
during and after labeling. At selected time points after labeling, 
mononuclear phagocytes subsets were stained and sorted by 
FACS Aria II (BD), DNA extracted, and deuterium enrich-
ment measured by gas chromatography mass spectrometry, as 
previously described (Busch et al., 2007; Macallan et al., 2009).
Modeling of data
A schematic of the model is shown in Fig. 1 e. We denote N as 
the number of monocytes in the bone marrow, B1 the number 
of classical monocytes in the blood, B2 the number of interme-
diate monocytes in the blood, and B3 the number of nonclassi-
cal monocytes in the blood. The dynamics between these four 
compartments can then described by the following equations:
  dN ___dt = pN −  r 1 N 
  d  B 1  ___dt =  r 1 N ( t −   Δ 1 ) −  r 2  B 1 
  d  B 2  ___dt =  α 2  r 2  B 1 −  r 3  B 2 
  d  B 3  ___dt =  α 3  r 3  B 2 ( t −   Δ 3 ) −  r 4  B 3 
We assume that all the compartments are in steady state. 
The relative sizes of B1, B2, and B3 were taken from flow 
cytometry data for each individual (Table  1). From these 
equations, we derive the dynamics of the fraction of labeled 
cells in each compartment: FN for the bone marrow and Fx 
for blood compartments Bx:
  d  F N  ___dt = pU ( t ) b −  r 1  F N 
  d  F 1  ___dt =  r 1  
N __  B 1  F N ( t −    Δ 1 ) −  r 2  F 1 
  d  F 2  ___dt =  α 2  r 2  
 B 1  __ B 2  F 1 −  r 3  F 2 
  d  F 3  ___dt =    α 3  r 3  
 B 2  __ B 3  F 2 ( t −   Δ 3 ) −  r 4  F 3 
Here, U(t) is the precursor enrichment (plasma glucose) 
at time t, described empirically as a plateau function with 
exponential decay.
We used the R packages modFit and dede to fit the 
model to the observed values of deuterium enrichment (Fx in 
Figure 3. development of intermediate and nonclassical human monocytes from classical monocytes. (a) Classical human monocyte LIN− HLA-DR+ 
CD14+ CD16− cells were sorted from healthy blood by FACS. (b) 1.5 × 106 sorted classical monocytes were grafted i.v. into the humanized MIS TRG mouse. 
Grafted cells could be readily identified by expression of the human isoform of CD45 compared with recipient leukocytes expressing mouse CD45. (c) Flow 
cytometry analysis identified human CD45+ circulating monocytes from MIS TRG recipients following adoptive transfer of human CD14+CD16− classical 
monocytes at 10 min and 24, 72, and 96 h after infusion. Results are representative of three analyzed mice per time point.
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the equations above). The fitting algorithm sought to minimize 
the sum of squared residuals between the modeled curves and 
observed values. This sum of squared residuals was translated 
into an Akaike information criterion (corrected for small sam-
ple sizes), allowing us to compare the models with and without 
Δ3 (because a model with more parameters will trivially result 
in an equal or better fit but comes with a risk of overfitting).
Intravenous administration of endotoxin. 2 ng/kg endotoxin 
(Escherichia coli 0:113; National Institutes of Health Clinical 
Center) was administered i.v. to 10 healthy male volunteers as 
described previously (Fullerton et al., 2016). At selected time 
points, blood samples were taken and analyzed by flow cy-
tometry. Three subjects received deuterium-labeled glucose 
20 h before endotoxin administration and monocyte labeling 
kinetics analyzed as above (Fig. 2 a).
Mice. 10-wk-old MIS TRG mice (Rongvaux et al., 2014; 
Deng et al., 2015) were used for adoptive transfer experi-
ments. Mice were maintained under specific pathogen–free 
conditions and handled under protocols approved by the Yale 
Institutional Animal Care and Use Committee.
Mouse adoptive transfer. Blood was collected from healthy 
volunteers and mononuclear phagocytes enriched using Ro-
setteSep Human Monocyte Enrichment Cocktail (STE MCE 
LL Technologies) following the manufacturer’s instructions. 
Enriched cells were labeled with CD3, CD19, CD20, CD56, 
CD66b, HLA-DR, CD14, and CD16 antibodies before sort-
ing classical monocytes by FACS AriaII (BD). Sorted classical 
monocytes were adoptively transferred intravenously into 
MIS TRG mice (Rongvaux et al., 2014; Deng et al., 2015). 
Peripheral blood was collected by cardiac puncture under 
terminal anesthesia; erythrocytes were lysed by ACK (Lonza). 
The leukocyte fraction was stained and analyzed by flow cy-
tometry. The fate of the classical monocytes were analyzed at 
selected time points after transfer identified as human 
mCD45−hCD45+HLA-DR+CD33+Lin− by flow cytometry.
online supplemental material
Fig. S1 quantifies human blood monocyte subset mem-
brane marker expression and cell cycle analysis. Fig. S2 
shows modeling curves generated with and without a 
delay between intermediate and nonclassical monocytes. 
Table S1 shows model data fit with and without a delay. 
Table S2 shows lifespans, proliferation rates, and delays for 
the model with a delay.
acknowledgMentS
We would like to thank the all the volunteers who participated in this study, Jamie 
Evans (UCL) for his assistance with the cell sorting, and Jonathan Alderman (Yale 
University) for coordinating phlebotomy and logistics. We thank our colleagues for 
useful discussions, especially Dr. A. Mildner and Dr. S. Jung.
A.A. Patel was supported by a PhD Studentship from the Engineering and 
Physical Sciences Research Council UK, and J.N. Fullerton was supported by the Well-
come Trust Clinical PhD Fellowship. D. Macallan received funding from the Medical 
Research Council UK (G1001052), The Wellcome Trust (project grant 093053/Z/10/Z), 
and Bloodwise (15012). B. Asquith is a Wellcome Trust Investigator (103865) and is 
funded by the Medical Research Council UK (J007439 and G1001052), the European 
Union Seventh Framework Program (FP7/2007–2013) under grant agreement 317040 
(QuanTI), and Leukemia and Lymphoma Research (15012).
The authors declare no competing financial interests.
Author contributions: S. Yona and D. Macallan conceived the project. S. Yona 
designed and performed all experiments and analysis except where otherwise speci-
fied and wrote the manuscript with D. Macallan. A.A. Patel performed all the human 
studies, except where otherwise stated. Y. Zhang processed and isolated DNA from 
sorted monocyte populations and performed gas chromatography mass spectrome-
try analysis. L. Boelen, B. Asquith, D. Macallan, and A.A. Patel wrote and performed 
the mathematical modeling. V. Bigley performed the comparison of bone marrow 
versus blood monocytes. J.N. Fullerton, S. Yona, A.A. Maini, and D.W. Gilroy performed 
the human endotoxin study. A. Rongvaux and R.A. Flavell provided the MIS TRG mice 
and assistance in the adoptive transfers of human monocytes and hosted S. Yona. S. 
Yona supervised the project.
Submitted: 23 February 2017
Revised: 28 April 2017
Accepted: 28 April 2017
reFerenceS
Arnold, L., A. Henry, F. Poron, Y. Baba-Amer, N. van Rooijen, A. Plonquet, 
R.K. Gherardi, and B. Chazaud. 2007. Inflammatory monocytes recruited 
after skeletal muscle injury switch into antiinflammatory macrophages to 
support myogenesis. J. Exp. Med. 204:1057–1069. http ://dx .doi .org /10 
.1084 /jem .20070075
Auffray, C., D. Fogg, M. Garfa, G. Elain, O. Join-Lambert, S. Kayal, S. Sarnacki, 
A. Cumano, G. Lauvau, and F. Geissmann. 2007. Monitoring of blood 
vessels and tissues by a population of monocytes with patrolling behavior. 
Science. 317:666–670. http ://dx .doi .org /10 .1126 /science .1142883
Avraham-Davidi, I., S. Yona, M. Grunewald, L. Landsman, C. Cochain, J.S. 
Silvestre, H. Mizrahi, M. Faroja, D. Strauss-Ayali, M. Mack, et al. 2013. 
On-site education of VEGF-recruited monocytes improves their 
performance as angiogenic and arteriogenic accessory cells. J. Exp. Med. 
210:2611–2625. http ://dx .doi .org /10 .1084 /jem .20120690
Bain, C.C., A. Bravo-Blas, C.L. Scott, E. Gomez Perdiguero, F. Geissmann, 
S. Henri, B. Malissen, L.C. Osborne, D. Artis, and A.M. Mowat. 2014. 
Constant replenishment from circulating monocytes maintains the 
macrophage pool in the intestine of adult mice. Nat. Immunol. 15:929–
937. http ://dx .doi .org /10 .1038 /ni .2967
Bigley, V., M. Haniffa, S. Doulatov, X.N. Wang, R. Dickinson, N. McGovern, L. 
Jardine, S. Pagan, I. Dimmick, I. Chua, et al. 2011. The human syndrome 
of dendritic cell, monocyte, B and NK lymphoid deficiency. J. Exp. Med. 
208:227–234. http ://dx .doi .org /10 .1084 /jem .20101459
Breton, G., J. Lee, K. Liu, and M.C. Nussenzweig. 2015. Defining human 
dendritic cell progenitors by multiparametric flow cytometry. Nat. 
Protoc. 10:1407–1422. http ://dx .doi .org /10 .1038 /nprot .2015 .092
Busch, R., R.A. Neese, M. Awada, G.M. Hayes, and M.K. Hellerstein. 2007. 
Measurement of cell proliferation by heavy water labeling. Nat. Protoc. 
2:3045–3057. http ://dx .doi .org /10 .1038 /nprot .2007 .420
Cooper, D.L., S.G. Martin, J.I. Robinson, S.L. Mackie, C.J. Charles, J. Nam, 
J.D. Isaacs, P. Emery, and A.W. Morgan. YEAR Consortium. 2012. 
FcγRIIIa expression on monocytes in rheumatoid arthritis: Role in 
immune-complex stimulated TNF production and non-response to 
methotrexate therapy. PLoS One. 7:e28918. http ://dx .doi .org /10 .1371 
/journal .pone .0028918
Cros, J., N. Cagnard, K. Woollard, N. Patey, S.Y. Zhang, B. Senechal, A. Puel, 
S.K. Biswas, D. Moshous, C. Picard, et al. 2010. Human CD14dim 
monocytes patrol and sense nucleic acids and viruses via TLR7 and 
TLR8 receptors. Immunity. 33:375–386. http ://dx .doi .org /10 .1016 /j 
.immuni .2010 .08 .012
o
n
 June 19, 2017
D
ow
nloaded from
 
Published June 12, 2017
Human monocyte kinetics | Patel et al.10
Davies, L.C., S.J. Jenkins, J.E. Allen, and P.R. Taylor. 2013. Tissue-resident 
macrophages. Nat. Immunol. 14:986–995. http ://dx .doi .org /10 .1038 /
ni .2705
Deng, K., M. Pertea, A. Rongvaux, L. Wang, C.M. Durand, G. Ghiaur, J. Lai, 
H.L. McHugh, H. Hao, H. Zhang, et al. 2015. Broad CTL response is 
required to clear latent HIV-1 due to dominance of escape mutations. 
Nature. 517:381–385. http ://dx .doi .org /10 .1038 /nature14053
Fogg, D.K., C. Sibon, C. Miled, S. Jung, P. Aucouturier, D.R. Littman, A. 
Cumano, and F. Geissmann. 2006. A clonogenic bone marrow progenitor 
specific for macrophages and dendritic cells. Science. 311:83–87. http ://
dx .doi .org /10 .1126 /science .1117729
Fullerton, J.N., E. Segre, R.P. De Maeyer, A.A. Maini, and D.W. Gilroy. 2016. 
Intravenous endotoxin challenge in healthy humans: An experimental 
platform to investigate and modulate systemic inflammation. J. Vis. Exp. 
e53913. http ://dx .doi .org /10 .3791 /53913
Gamrekelashvili, J., R. Giagnorio, J. Jussofie, O. Soehnlein, J. Duchene, C.G. 
Briseño, S.K. Ramasamy, K. Krishnasamy, A. Limbourg, T. Kapanadze, et 
al. 2016. Regulation of monocyte cell fate by blood vessels mediated by 
Notch signalling. Nat. Commun. 7:12597. http ://dx .doi .org /10 .1038 /
ncomms12597
Geissmann, F., S. Jung, and D.R. Littman. 2003. Blood monocytes consist 
of two principal subsets with distinct migratory properties. Immunity. 
19:71–82. http ://dx .doi .org /10 .1016 /S1074 -7613(03)00174 -2
Ginhoux, F., and S. Jung. 2014. Monocytes and macrophages: Developmental 
pathways and tissue homeostasis. Nat. Rev. Immunol. 14:392–404. http ://
dx .doi .org /10 .1038 /nri3671
Ginhoux, F., M. Greter, M. Leboeuf, S. Nandi, P. See, S. Gokhan, M.F. Mehler, 
S.J. Conway, L.G. Ng, E.R. Stanley, et al. 2010. Fate mapping analysis 
reveals that adult microglia derive from primitive macrophages. Science. 
330:841–845. http ://dx .doi .org /10 .1126 /science .1194637
Griseri, T., B.S. McKenzie, C. Schiering, and F. Powrie. 2012. Dysregulated 
hematopoietic stem and progenitor cell activity promotes interleukin-
23-driven chronic intestinal inflammation. Immunity. 37:1116–1129. 
http ://dx .doi .org /10 .1016 /j .immuni .2012 .08 .025
Guilliams, M., I. De Kleer, S. Henri, S. Post, L. Vanhoutte, S. De Prijck, K. 
Deswarte, B. Malissen, H. Hammad, and B.N. Lambrecht. 2013. Alveolar 
macrophages develop from fetal monocytes that differentiate into long-
lived cells in the first week of life via GM-CSF. J. Exp. Med. 210:1977–
1992. http ://dx .doi .org /10 .1084 /jem .20131199
Guilliams, M., F. Ginhoux, C. Jakubzick, S.H. Naik, N. Onai, B.U. Schraml, 
E. Segura, R. Tussiwand, and S. Yona. 2014. Dendritic cells, monocytes 
and macrophages: A unified nomenclature based on ontogeny. Nat. Rev. 
Immunol. 14:571–578. http ://dx .doi .org /10 .1038 /nri3712
Hashimoto, D., A. Chow, C. Noizat, P. Teo, M.B. Beasley, M. Leboeuf, C.D. 
Becker, P. See, J. Price, D. Lucas, et al. 2013. Tissue-resident macrophages 
self-maintain locally throughout adult life with minimal contribution 
from circulating monocytes. Immunity. 38:792–804. http ://dx .doi .org 
/10 .1016 /j .immuni .2013 .04 .004
Heidt, T., H.B. Sager, G. Courties, P. Dutta, Y. Iwamoto, A. Zaltsman, C. von 
Zur Muhlen, C. Bode, G.L. Fricchione, J. Denninger, et al. 2014. Chronic 
variable stress activates hematopoietic stem cells. Nat. Med. 20:754–758. 
http ://dx .doi .org /10 .1038 /nm .3589
Hettinger, J., D.M. Richards, J. Hansson, M.M. Barra, A.C. Joschko, J. 
Krijgsveld, and M. Feuerer. 2013. Origin of monocytes and macrophages 
in a committed progenitor. Nat. Immunol. 14:821–830. http ://dx .doi .org 
/10 .1038 /ni .2638
Ingersoll, M.A., R. Spanbroek, C. Lottaz, E.L. Gautier, M. Frankenberger, 
R. Hoffmann, R. Lang, M. Haniffa, M. Collin, F. Tacke, et al. 2010. 
Comparison of gene expression profiles between human and mouse 
monocyte subsets. Blood. 115:e10–e19. http ://dx .doi .org /10 .1182 /
blood -2009 -07 -235028
Jakubzick, C., E.L. Gautier, S.L. Gibbings, D.K. Sojka, A. Schlitzer, T.E. 
Johnson, S. Ivanov, Q. Duan, S. Bala, T. Condon, et al. 2013. Minimal 
differentiation of classical monocytes as they survey steady-state tissues 
and transport antigen to lymph nodes. Immunity. 39:599–610. http ://dx 
.doi .org /10 .1016 /j .immuni .2013 .08 .007
Lahoz-Beneytez, J., M. Elemans, Y. Zhang, R. Ahmed, A. Salam, M. Block, C. 
Niederalt, B. Asquith, and D. Macallan. 2016. Human neutrophil kinetics: 
Modeling of stable isotope labeling data supports short blood neutrophil 
half-lives. Blood. 127:3431–3438. http ://dx .doi .org /10 .1182 /blood 
-2016 -03 -700336
Lee, J., G. Breton, T.Y. Oliveira, Y.J. Zhou, A. Aljoufi, S. Puhr, M.J. Cameron, 
R.P. Sékaly, M.C. Nussenzweig, and K. Liu. 2015. Restricted dendritic 
cell and monocyte progenitors in human cord blood and bone marrow. 
J. Exp. Med. 212:385–399. http ://dx .doi .org /10 .1084 /jem .20141442
Liao, C.T., R. Andrews, L.E. Wallace, M.W. Khan, A. Kift-Morgan, N. Topley, 
D.J. Fraser, and P.R. Taylor. 2017. Peritoneal macrophage heterogeneity 
is associated with different peritoneal dialysis outcomes. Kidney Int. 
91:1088–1103. http ://dx .doi .org /10 .1016 /j .kint .2016 .10 .030
Liu, K., G.D. Victora, T.A. Schwickert, P. Guermonprez, M.M. Meredith, K. 
Yao, F.F. Chu, G.J. Randolph, A.Y. Rudensky, and M. Nussenzweig. 2009. 
In vivo analysis of dendritic cell development and homeostasis. Science. 
324:392–397. http ://dx .doi .org /10 .1126 /science .1170540
Macallan, D.C., C.A. Fullerton, R.A. Neese, K. Haddock, S.S. Park, and M.K. 
Hellerstein. 1998. Measurement of cell proliferation by labeling of DNA 
with stable isotope-labeled glucose: Studies in vitro, in animals, and in 
humans. Proc. Natl. Acad. Sci. USA. 95:708–713. http ://dx .doi .org /10 
.1073 /pnas .95 .2 .708
Macallan, D.C., B. Asquith, Y. Zhang, C. de Lara, H. Ghattas, J. Defoiche, and 
P.C. Beverley. 2009. Measurement of proliferation and disappearance 
of rapid turnover cell populations in human studies using deuterium-
labeled glucose. Nat. Protoc. 4:1313–1327. http ://dx .doi .org /10 .1038 /
nprot .2009 .117
Mass, E., I. Ballesteros, M. Farlik, F. Halbritter, P. Günther, L. Crozet, C.E. 
Jacome-Galarza, K. Händler, J. Klughammer, Y. Kobayashi, et al. 2016. 
Specification of tissue-resident macrophages during organogenesis. 
Science. 353:aaf4238.
Mildner, A., E. Chapnik, O. Manor, S. Yona, K.W. Kim, T. Aychek, D. Varol, G. 
Beck, Z.B. Itzhaki, E. Feldmesser, et al. 2013a. Mononuclear phagocyte 
miRNome analysis identifies miR-142 as critical regulator of murine 
dendritic cell homeostasis. Blood. 121:1016–1027.
Mildner, A., S. Yona, and S. Jung. 2013b. A close encounter of the third kind: 
Monocyte-derived cells. Adv. Immunol. 120:69–103. http ://dx .doi .org 
/10 .1016 /B978 -0 -12 -417028 -5 .00003 -X
Nahrendorf, M., F.K. Swirski, E. Aikawa, L. Stangenberg, T. Wurdinger, J.-L. 
Figueiredo, P. Libby, R. Weissleder, and M.J. Pittet. 2007. The healing 
myocardium sequentially mobilizes two monocyte subsets with 
divergent and complementary functions. J. Exp. Med. 204:3037–3047. 
http ://dx .doi .org /10 .1084 /jem .20070885
Naik, S.H., P. Sathe, H.Y. Park, D. Metcalf, A.I. Proietto, A. Dakic, S. Carotta, 
M. O’Keeffe, M. Bahlo, A. Papenfuss, et al. 2007. Development of 
plasmacytoid and conventional dendritic cell subtypes from single 
precursor cells derived in vitro and in vivo. Nat. Immunol. 8:1217–1226. 
http ://dx .doi .org /10 .1038 /ni1522
Onai, N., A. Obata-Onai, M.A. Schmid, T. Ohteki, D. Jarrossay, and M.G. 
Manz. 2007. Identification of clonogenic common Flt3+M-CSFR+ 
plasmacytoid and conventional dendritic cell progenitors in mouse bone 
marrow. Nat. Immunol. 8:1207–1216. http ://dx .doi .org /10 .1038 /ni1518
Onai, N., K. Kurabayashi, M. Hosoi-Amaike, N. Toyama-Sorimachi, K. 
Matsushima, K. Inaba, and T. Ohteki. 2013. A clonogenic progenitor 
with prominent plasmacytoid dendritic cell developmental potential. 
Immunity. 38:943–957. http ://dx .doi .org /10 .1016 /j .immuni .2013 .04 
.006
Passlick, B., D. Flieger, and H.W. Ziegler-Heitbrock. 1989. Identification and 
characterization of a novel monocyte subpopulation in human periph-
eral blood. Blood. 74:2527–2534.
o
n
 June 19, 2017
D
ow
nloaded from
 
Published June 12, 2017
11JEM
Rongvaux, A., T. Willinger, J. Martinek, T. Strowig, S.V. Gearty, L.L. Teichmann, 
Y. Saito, F. Marches, S. Halene, A.K. Palucka, et al. 2014. Development and 
function of human innate immune cells in a humanized mouse model. 
Nat. Biotechnol. 32:364–372. http ://dx .doi .org /10 .1038 /nbt .2858
Schulz, C., E. Gomez Perdiguero, L. Chorro, H. Szabo-Rogers, N. Cagnard, 
K. Kierdorf, M. Prinz, B. Wu, S.E. Jacobsen, J.W. Pollard, et al. 2012. A 
lineage of myeloid cells independent of Myb and hematopoietic stem 
cells. Science. 336:86–90. http ://dx .doi .org /10 .1126 /science .1219179
Serbina, N.V., and E.G. Pamer. 2006. Monocyte emigration from bone 
marrow during bacterial infection requires signals mediated by 
chemokine receptor CCR2. Nat. Immunol. 7:311–317. http ://dx .doi 
.org /10 .1038 /ni1309
Shi, C., and E.G. Pamer. 2011. Monocyte recruitment during infection and 
inflammation. Nat. Rev. Immunol. 11:762–774. http ://dx .doi .org /10 
.1038 /nri3070
Shi, C., T. Jia, S. Mendez-Ferrer, T.M. Hohl, N.V. Serbina, L. Lipuma, I. Leiner, 
M.O. Li, P.S. Frenette, and E.G. Pamer. 2011. Bone marrow mesenchymal 
stem and progenitor cells induce monocyte emigration in response to 
circulating toll-like receptor ligands. Immunity. 34:590–601. http ://dx 
.doi .org /10 .1016 /j .immuni .2011 .02 .016
Soucie, E.L., Z. Weng, L. Geirsdóttir, K. Molawi, J. Maurizio, R. Fenouil, 
N. Mossadegh-Keller, G. Gimenez, L. VanHille, M. Beniazza, et al. 2016. 
Lineage-specific enhancers activate self-renewal genes in macrophages 
and embryonic stem cells. Science. 351:aad5510. http ://dx .doi .org /10 
.1126 /science .aad5510
Sunderkötter, C., T. Nikolic, M.J. Dillon, N. Van Rooijen, M. Stehling, 
D.A. Drevets, and P.J. Leenen. 2004. Subpopulations of mouse blood 
monocytes differ in maturation stage and inflammatory response. J. 
Immunol. 172:4410–4417. http ://dx .doi .org /10 .4049 /jimmunol .172 .7 
.4410
Tamoutounour, S., M. Guilliams, F. Montanana Sanchis, H. Liu, D. Terhorst, C. 
Malosse, E. Pollet, L. Ardouin, H. Luche, C. Sanchez, et al. 2013. Origins 
and functional specialization of macrophages and of conventional and 
monocyte-derived dendritic cells in mouse skin. Immunity. 39:925–938. 
http ://dx .doi .org /10 .1016 /j .immuni .2013 .10 .004
Thomas, G.D., R.N. Hanna, N.T. Vasudevan, A.A. Hamers, C.E. Romanoski, 
S. McArdle, K.D. Ross, A. Blatchley, D. Yoakum, B.A. Hamilton, et al. 
2016. Deleting an Nr4a1 super-enhancer subdomain ablates Ly6C(low) 
monocytes while preserving macrophage gene function. Immunity. 
45:975–987. http ://dx .doi .org /10 .1016 /j .immuni .2016 .10 .011
Urra, X., N. Villamor, S. Amaro, M. Gómez-Choco, V. Obach, L. Oleaga, 
A.M. Planas, and A. Chamorro. 2009. Monocyte subtypes predict clinical 
course and prognosis in human stroke. J. Cereb. Blood Flow Metab. 29:994–
1002. http ://dx .doi .org /10 .1038 /jcbfm .2009 .25
van Furth, R., and Z.A. Cohn. 1968. The origin and kinetics of mononuclear 
phagocytes. J. Exp. Med. 128:415–435. http ://dx .doi .org /10 .1084 /jem 
.128 .3 .415
van Furth, R., Z.A. Cohn, J.G. Hirsch, J.H. Humphrey, W.G. Spector, and 
H.L. Langevoort. 1972. [Mononuclear phagocytic system: new classifica-
tion of macrophages, monocytes and of their cell line]. Bull. World Health 
Organ. 47:651–658.
Varol, C., L. Landsman, D.K. Fogg, L. Greenshtein, B. Gildor, R. Margalit, 
V. Kalchenko, F. Geissmann, and S. Jung. 2007. Monocytes give rise 
to mucosal, but not splenic, conventional dendritic cells. J. Exp. Med. 
204:171–180. http ://dx .doi .org /10 .1084 /jem .20061011
Varol, C., A. Vallon-Eberhard, E. Elinav, T. Aychek, Y. Shapira, H. Luche, H.J. 
Fehling, W.D. Hardt, G. Shakhar, and S. Jung. 2009. Intestinal lamina 
propria dendritic cell subsets have different origin and functions. 
Immunity. 31:502–512. http ://dx .doi .org /10 .1016 /j .immuni .2009 .06 
.025
Vukmanovic-Stejic, M., Y. Zhang, J.E. Cook, J.M. Fletcher, A. McQuaid, J.E. 
Masters, M.H. Rustin, L.S. Taams, P.C. Beverley, D.C. Macallan, and A.N. 
Akbar. 2006. Human CD4+ CD25hi Foxp3+ regulatory T cells are 
derived by rapid turnover of memory populations in vivo. J. Clin. Invest. 
116:2423–2433. http ://dx .doi .org /10 .1172 /JCI28941
Westera, L., Y. Zhang, K. Tesselaar, J.A.M. Borghans, and D.C. Macallan. 2013. 
Quantitating lymphocyte homeostasis in vivo in humans using stable 
isotope tracers. Methods Mol. Biol. 979:107–131. http ://dx .doi .org /10 
.1007 /978 -1 -62703 -290 -2 _10
Wong, K.L., J.J. Tai, W.C. Wong, H. Han, X. Sem, W.H. Yeap, P. Kourilsky, 
and S.C. Wong. 2011. Gene expression profiling reveals the defining 
features of the classical, intermediate, and nonclassical human monocyte 
subsets. Blood. 118:e16–e31. http ://dx .doi .org /10 .1182 /blood -2010 -12 
-326355
Wynn, T.A., A. Chawla, and J.W. Pollard. 2013. Macrophage biology in 
development, homeostasis and disease. Nature. 496:445–455. http ://dx 
.doi .org /10 .1038 /nature12034
Yona, S., and S. Gordon. 2015. From the reticuloendothelial to mononuclear 
phagocyte system - The unaccounted years. Front. Immunol. 6:328. http 
://dx .doi .org /10 .3389 /fimmu .2015 .00328
Yona, S., K.W. Kim, Y. Wolf, A. Mildner, D. Varol, M. Breker, D. Strauss-
Ayali, S. Viukov, M. Guilliams, A. Misharin, et al. 2013. Fate mapping 
reveals origins and dynamics of monocytes and tissue macrophages 
under homeostasis. Immunity. 38:79–91. (published erratum appears in 
Immunity. 2013. 38:1073-1079) http ://dx .doi .org /10 .1016 /j .immuni 
.2012 .12 .001
Yrlid, U., C.D. Jenkins, and G.G. MacPherson. 2006. Relationships between 
distinct blood monocyte subsets and migrating intestinal lymph dendritic 
cells in vivo under steady-state conditions. J. Immunol. 176:4155–4162. 
http ://dx .doi .org /10 .4049 /jimmunol .176 .7 .4155
Zhang, Y., C. de Lara, A. Worth, A. Hegedus, K. Laamanen, P. Beverley, and D. 
Macallan. 2013. Accelerated in vivo proliferation of memory phenotype 
CD4+ T-cells in human HIV-1 infection irrespective of viral chemokine 
co-receptor tropism. PLoS Pathog. 9:e1003310. http ://dx .doi .org /10 
.1371 /journal .ppat .1003310
Ziegler-Heitbrock, H.W., E. Thiel, A. Fütterer, V. Herzog, A. Wirtz, and G. 
Riethmüller. 1988. Establishment of a human cell line (Mono Mac 6) 
with characteristics of mature monocytes. Int. J. Cancer. 41:456–461. http 
://dx .doi .org /10 .1002 /ijc .2910410324
Ziegler-Heitbrock, L., P. Ancuta, S. Crowe, M. Dalod, V. Grau, D.N. Hart, P.J. 
Leenen, Y.J. Liu, G. MacPherson, G.J. Randolph, et al. 2010. Nomenclature 
of monocytes and dendritic cells in blood. Blood. 116:e74–e80. http ://
dx .doi .org /10 .1182 /blood -2010 -02 -258558
Zigmond, E., S. Samia-Grinberg, M. Pasmanik-Chor, E. Brazowski, O. 
Shibolet, Z. Halpern, and C. Varol. 2014. Infiltrating monocyte-derived 
macrophages and resident Kupffer cells display different ontogeny and 
functions in acute liver injury. J. Immunol. 193:344–353. http ://dx .doi 
.org /10 .4049 /jimmunol .1400574
o
n
 June 19, 2017
D
ow
nloaded from
 
Published June 12, 2017
